Advancing automation in high-throughput screening: Modular unguarded systems enable adaptable drug discovery

Catherine S Hansel1, Darren L Plant1, Geoffrey A Holdgate1

  • 1High-Throughput Screening, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, UK.

Drug Discovery Today
|March 19, 2022
PubMed
Summary

AstraZeneca